Quantbot Technologies LP Concert Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.69 - $4.22 $2,781 - $4,363	-1,034 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.77 - $5.24 $3,898 - $5,418	1,034 New	1,034 $4,000
Q1 2021 May 14, 2021	SELL	$4.86 - $13.07 $2,430 - $6,535	-500 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$9.48 - $12.84 $4,740 - $6,420	500 New	500 $6,000
Q4 2018 Feb 13, 2019	SELL	$11.25 - $16.17 $39,881 - $57,322	-3,545 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$12.82 - $17.88 $16,089 - $22,439	1,255 Added 54.8%	3,545 $52,000
Q2 2018 Aug 13, 2018	BUY	$16.83 - $21.66 $38,540 - $49,601	2,290 New	2,290 $38,000
Q1 2018 May 11, 2018	SELL	$19.24 - $28.03 $127,137 - $185,222	-6,608 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$13.96 - $29.05 $92,247 - $191,962	6,608	6,608 $170,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.